Earnings Per Share, Basic in USD/shares of CATALYST PHARMACEUTICALS, INC. from Q2 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Catalyst Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2018 to Q3 2025.
  • Catalyst Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was 0.43 USD/shares, a 16.2% increase year-over-year.
  • Catalyst Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was 1 USD/shares, a 44.4% increase year-over-year.
  • Catalyst Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2024 was 1.38 USD/shares, a 106% increase from 2023.
  • Catalyst Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was 0.67 USD/shares, a 16.3% decline from 2022.
  • Catalyst Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was 0.8 USD/shares, a 111% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

CATALYST PHARMACEUTICALS, INC. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $1.00 $0.43 +$0.06 +16.2% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $1.00 $0.43 +$0.08 +22.9% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $1.00 $0.47 +$0.27 +135% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q4 2024 $1.00 $0.46 +$0.14 +43.8% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-26
Q3 2024 $1.00 $0.37 +$0.66 Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q2 2024 $0 $0.35 $0 -2.78% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 $0 $0.20 $0 -28.6% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q4 2023 $0 $0.32 +$0.08 +33.3% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-26
Q3 2023 $0 $0 -$1 -232% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $1.00 $0.36 +$0.15 +71.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $0 $0.28 +$0.15 +115% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $0 $0.24 +$0.15 +167% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-26
Q3 2022 $0 $0.22 +$0.12 +120% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $0 $0.21 +$0.09 +75% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $0 $0.13 +$0.06 +85.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $0 $0.09 $0 -18.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $0 $0.10 $0 -76.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $0 $0.12 +$0.03 +33.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $0 $0.07 $0 -30% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $0 $0.11 +$0.03 +37.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-15
Q3 2020 $0 $0.42 +$0.29 +223% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $0 $0.09 $0 -18.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $0 $0.10 +$0.11 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $0 $0.08 Oct 1, 2019 Dec 31, 2019 10-K 2020-03-16
Q3 2019 $0.13 +$0.21 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $0.11 +$0.17 Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q3 2018 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07

CATALYST PHARMACEUTICALS, INC. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.38 +$0.71 +106% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-26
2023 $0.67 $0 -16.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-26
2022 $0.80 +$0.42 +111% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-26
2021 $0.38 $0 -47.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $0.72 +$0.41 +132% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-15
2019 $0.31 +$0.64 Jan 1, 2019 Dec 31, 2019 10-K 2022-03-16
2018 $0 Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.